Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 10, pp. 1136-1149
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 5, 2018
- Revision received June 12, 2018
- Accepted August 17, 2018
- Published first August 21, 2018.
Article Versions
- Previous version (August 21, 2018 - 06:51).
- Previous version (September 24, 2018 - 06:59).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Stephen B. Willingham*,
- Po Y. Ho,
- Andrew Hotson,
- Craig Hill,
- Emily C. Piccione,
- Jessica Hsieh,
- Liang Liu,
- Joseph J. Buggy,
- Ian McCaffery, and
- Richard A. Miller
- ↵*Corresponding Author:
Stephen B. Willingham, Corvus Pharmaceuticals, 863 Mitten Road, Suite 102, Burlingame, CA 94010. Phone: 650-900-4527; Fax: 844-463-2039; E-mail: swillingham{at}corvuspharma.com
October 2018
Volume 6, Issue 10
Volume 6, Issue 10
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
Jump to section
Advertisement